What partnership costs

Structured medication reviews: prescribing change is not the same as medicines optimisationSheppard and colleagues provide an important evaluation of structured medication reviews (SMRs) in English primary care.Their findings are encouraging: SMRs appear to have reached patients with frailty, multimorbidity, and polypharmacy, and were associated with starting and stopping medicines. 1However, because the study could not determine whether these changes improved outcomes, it raises a harder question: when has an SMR 'worked'?From a medicines optimisation standpoint, prescribing movement is not necessarily better care.Starting a medicine may be appropriate, but may add burden.Stopping a medicine may reduce risk, whereas continuing a potentially problematic medicine may be justified after discussion with the patient.Counts of medicines started or stopped show that something changed, not whether the change was necessary, person centred, or beneficial.

Authors

Institutions

Publication Details

Journal
British Journal of General Practice
Published
2026-07-30
DOI
https://doi.org/10.3399/bjgp26x746133
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What partnership costs

Sam Hilton
British Journal of General Practice
Biotechnology and Related Fields
article

What partnership costs

Sam Hilton
article en

Abstract

Structured medication reviews: prescribing change is not the same as medicines optimisationSheppard and colleagues provide an important evaluation of structured medication reviews (SMRs) in English primary care.Their findings are encouraging: SMRs appear to have reached patients with frailty, multimorbidity, and polypharmacy, and were associated with starting and stopping medicines. 1However, because the study could not determine whether these changes improved outcomes, it raises a harder question: when has an SMR 'worked'?From a medicines optimisation standpoint, prescribing movement is not necessarily better care.Starting a medicine may be appropriate, but may add burden.Stopping a medicine may reduce risk, whereas continuing a potentially problematic medicine may be justified after discussion with the patient.Counts of medicines started or stopped show that something changed, not whether the change was necessary, person centred, or beneficial.

British Journal of General PracticeVol. 76(769)
NHS Digital (GB)
Partnerships for the goals
Openalex Percentile: Top 7%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.